January 31st 2024, 10:00pm
Welireg outperformed Afinitor in time to disease progression and patient-reported quality of life in the treatment of metastatic clear cell renal cell carcinoma.
Sometime Risk for Breast Cancer is All in the Family
Cancer Survivors Can Get Tired of Being Called ‘Strong’
‘Key Signs’ of Cytokine Release Syndrome to Know
FDA Grants Fast Track Designation to CTX-009 in Biliary Tract Cancer